Cécile Macé
Impact in
-
- Antibiotic Use and Resistance
- Economics and Econometrics top 5%
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
Papers in
-
- Pharmaceutical Economics and Policy 7
- Health Systems, Economic Evaluations, Quality of Life 2
-
- Pharmaceutical Quality and Counterfeiting 4
- Biotechnology and Related Fields 1
- Co-authors
- Nathan Ford (1 shared paper)J. Pinel (1 shared paper)Myriam Henkens (1 shared paper)Karen Bissell (1 shared paper)Jane Robertson (1 shared paper)Gilles Forte (1 shared paper)Kees de Joncheere (1 shared paper)David Beran (1 shared paper)
- Journals
- Research in Social and Administrative Pharmacy (1 paper)Globalization and Health (1 paper)PharmacoEconomics (1 paper)Journal of Pharmaceutical Policy and Practice (1 paper)BMJ Global Health (1 paper)
- Partner nations
- SwitzerlandFranceBelgium
In The Last Decade
Cécile Macé
7 papers receiving 304 citations
Peers
Comparison fields: 5 of 63
- Applied Microbiology and Biotechnology 27
- Economics and Econometrics 197
- Public Health, Environmental and Occupational Health 179
- Management of Technology and Innovation 30
- Finance 32
Countries citing papers authored by Cécile Macé
This map shows the geographic impact of Cécile Macé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Macé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Macé more than expected).
Fields of papers citing papers by Cécile Macé
This network shows the impact of papers produced by Cécile Macé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Macé. The network helps show where Cécile Macé may publish in the future.
Co-authors
The 20 scholars most cited alongside Cécile Macé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 189 | |
| 2 | 2013 | 72 | |
| 3 | 2015 | 36 | |
| 4 | 2022 | 17 | |
| 5 | 2012 | 12 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 2 |
About Cécile Macé
Cécile Macé is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health, Management of Technology and Innovation, Pediatrics, Perinatology and Child Health and Infectious Diseases, having authored 7 papers that have together received 331 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (7 papers), Pharmaceutical Quality and Counterfeiting (4 papers), Intellectual Property and Patents (3 papers), Pharmaceutical studies and practices (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Global Public Health Policies and Epidemiology (1 paper), Biotechnology and Related Fields (1 paper) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (27 citations), Economics and Econometrics (197 citations), Public Health, Environmental and Occupational Health (179 citations), Management of Technology and Innovation (30 citations) and Finance (32 citations). Cécile Macé has collaborated with scholars based in Switzerland, France and Belgium. Frequent co-authors include Nathan Ford, J. Pinel, Myriam Henkens, Karen Bissell, Jane Robertson, Gilles Forte, Kees de Joncheere, David Beran, Lembit Rägo and Raffaella Ravinetto. Their work appears in journals such as Research in Social and Administrative Pharmacy, Globalization and Health, PharmacoEconomics, Journal of Pharmaceutical Policy and Practice and BMJ Global Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.